Advertisement

Clinical Implications of Lung Cancer

  • Paris A. Kosmidis
Chapter

Abstract

For several years, efforts have been undertaken to increase the number of operable patients by making the diagnosis earlier in presymptomatic stage, in an effort to eliminate mortality.

References

  1. 1.
    The National Lung Screening Trial Research Team (2011) Reduced lung cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409CrossRefGoogle Scholar
  2. 2.
    Swensen SJ, Viggiano RW, Midthum DE et al (2000) Lung nodule enhancement at CT: multicentre study. Radiology 214:73–80CrossRefGoogle Scholar
  3. 3.
    Tournoy KG, Keller SM, Annerma JT (2012) Mediastinal staging of lung cancer: novel concepts. Lancet Oncol 13:221–229CrossRefGoogle Scholar
  4. 4.
    Gould MK, Kuschner WG, Rydzak CE et al (2003) Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small cell lung cancer, a meta-analysis. Ann Intern Med 139:879–892CrossRefGoogle Scholar
  5. 5.
    Reed CE, Harpole DH, Posther KE et al (2003) Results of the American College of Surgeons Oncology Group ZOO50 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 126:1943–1951CrossRefGoogle Scholar
  6. 6.
    Van Tinteron H, Hoekstra OS, Smit EF et al (2002) Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small cell lung cancer: the PLUS multicentre randomised trial. Lancet 359:1388–1392CrossRefGoogle Scholar
  7. 7.
    Gu P, Zhao YZ, Juang LY et al (2009) Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis. Eur J Cancer 45:1389–1396CrossRefGoogle Scholar
  8. 8.
    Navani N, Brown JM, Nankivell M et al (2012) Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer. A multicentre study of 774 patients. Am J Resp Crit Care Med 185:1316–1322CrossRefGoogle Scholar
  9. 9.
    Skoura E, Datseris IE, Platis I et al (2012) Role of positron emission tomography in the early prediction of response to chemotherapy in patients with non-small cell lung cancer. Clin Lung Cancer 13:181–187CrossRefGoogle Scholar
  10. 10.
    Benamore R, Shepherd FA, Leighl N et al (2007) Does intensive follow-up alter outcome in patients with advanced lung cancer. J Thorac Oncol 2(4):273–281CrossRefGoogle Scholar
  11. 11.
    Westeel V, Choma D, Clement F et al (2000) Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg 70:1185–1190CrossRefGoogle Scholar
  12. 12.
    Schmidt-Hansen M, Baldwin D, Hasler E et al (2012) What is the most effective follow-up model for lung cancer patients? A systematic review. J Thorac Oncol 7(5):821–824CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Medical Oncologist, Head, Medical Oncology DepartmentHygeia HospitalAthensGreece

Personalised recommendations